Penn. paying for counter-detailing
“If you just practice smart, you'll be able to give better care and, by the way, save money,” Avorn said. He first developed an academic detailing program 25 years ago while in medical school.
The FDA discusses working with Google to identify unknown drug side effects; Tavenner named chief of insurer lobby group; drugmakers are starting to use cultural experts to better understand patient ...
Pharma's efforts to evolve restrictions about off-label marketing move forward.
Eli Lilly's lung-cancer antibody, necitumumab, has incremental benefits, according to an FDA advisory panel.